Document and Entity Information
Document and Entity Information - USD ($) $ in Millions | 12 Months Ended | ||
Jun. 30, 2017 | Aug. 21, 2017 | Dec. 31, 2016 | |
Document and Entity Information [Abstract] | |||
Entity Registrant Name | SHARPS COMPLIANCE CORP | ||
Entity Central Index Key | 898,770 | ||
Current Fiscal Year End Date | --06-30 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Filer Category | Accelerated Filer | ||
Entity Public Float | $ 48.8 | ||
Entity Common Stock, Shares Outstanding | 16,008,412 | ||
Document Fiscal Year Focus | 2,017 | ||
Document Fiscal Period Focus | FY | ||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Jun. 30, 2017 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2017 | Jun. 30, 2016 |
CURRENT ASSETS | ||
Cash and cash equivalents | $ 4,675 | $ 12,435 |
Accounts receivable, net | 7,553 | 5,814 |
Inventory, net | 4,098 | 3,919 |
Prepaid and other current assets | 694 | 695 |
TOTAL CURRENT ASSETS | 17,020 | 22,863 |
PROPERTY, PLANT AND EQUIPMENT, net | 6,543 | 5,032 |
OTHER ASSETS | 120 | 84 |
GOODWILL | 6,735 | 1,039 |
INTANGIBLE ASSETS, net | 4,046 | 1,129 |
TOTAL ASSETS | 34,464 | 30,147 |
CURRENT LIABILITIES | ||
Accounts payable | 1,710 | 1,620 |
Accrued liabilities | 1,800 | 1,534 |
Current maturities of long-term debt | 601 | 0 |
Deferred revenue | 2,421 | 2,477 |
TOTAL CURRENT LIABILITIES | 6,532 | 5,631 |
LONG-TERM DEFERRED REVENUE, net of current portion | 478 | 483 |
OTHER LONG-TERM LIABILITIES | 165 | 190 |
LONG-TERM DEBT, net of current portion | 2,002 | 0 |
TOTAL LIABILITIES | 9,177 | 6,304 |
COMMITMENTS AND CONTINGENCIES (Note 8) | ||
STOCKHOLDERS' EQUITY | ||
Common stock, $0.01 par value per share; 20,000,000 shares authorized; 16,304,027 and 15,740,458 shares issued, respectively and 16,008,412 and 15,444,843 shares outstanding, respectively. | 163 | 158 |
Treasury stock, at cost, 295,615 shares repurchased | (1,554) | (1,554) |
Additional paid-in capital | 28,063 | 25,331 |
Accumulated deficit | (1,385) | (92) |
TOTAL STOCKHOLDERS' EQUITY | 25,287 | 23,843 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 34,464 | $ 30,147 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Jun. 30, 2017 | Jun. 30, 2016 |
STOCKHOLDERS' EQUITY | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 20,000,000 | 20,000,000 |
Common stock, shares issued (in shares) | 16,304,027 | 15,740,458 |
Common stock, shares outstanding (in shares) | 16,008,412 | 15,444,843 |
Treasury stock, shares repurchased (in shares) | 295,615 | 295,615 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] | |||
REVENUES | $ 38,188 | $ 33,383 | $ 30,902 |
Cost of revenues | 26,351 | 22,272 | 19,907 |
GROSS PROFIT | 11,837 | 11,111 | 10,995 |
Selling, general and administrative | 12,223 | 10,812 | 9,496 |
Depreciation and amortization | 801 | 294 | 263 |
OPERATING INCOME (LOSS) | (1,187) | 5 | 1,236 |
OTHER INCOME (EXPENSE) | |||
Interest income | 13 | 32 | 36 |
Interest expense | (115) | 0 | 0 |
TOTAL OTHER (EXPENSE) INCOME | (102) | 32 | 36 |
INCOME (LOSS) BEFORE INCOME TAXES | (1,289) | 37 | 1,272 |
INCOME TAX EXPENSE - Current | 4 | 24 | 112 |
NET INCOME (LOSS) | $ (1,293) | $ 13 | $ 1,160 |
NET INCOME (LOSS) PER COMMON SHARE | |||
Basic (in dollars per share) | $ (0.08) | $ 0 | $ 0.08 |
Diluted (in dollars per share) | $ (0.08) | $ 0 | $ 0.07 |
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME (LOSS) PER COMMON SHARE: | |||
Basic (in shares) | 15,949 | 15,448 | 15,327 |
Diluted (in shares) | 15,949 | 15,838 | 15,564 |
CONSOLIDATED STATEMENTS OF STOC
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Common Stock [Member] | Treasury Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Total |
Balances at Jun. 30, 2014 | $ 155 | $ (681) | $ 23,695 | $ (1,265) | $ 21,904 |
Balances (in shares) at Jun. 30, 2014 | 15,460,940 | (161,801) | |||
Exercise of stock options | $ 0 | $ 0 | 139 | 0 | 139 |
Exercise of stock options (in shares) | 61,109 | 0 | |||
Stock-based compensation | $ 0 | $ 0 | 511 | 0 | 511 |
Issuance of restricted stock | $ 1 | $ 0 | (1) | 0 | 0 |
Issuance of restricted stock (in shares) | 52,992 | 0 | |||
Shares repurchased | $ 0 | $ (128) | 0 | 0 | $ (128) |
Shares repurchased (in shares) | 0 | (29,449) | (29,449) | ||
Net income (loss) | $ 0 | $ 0 | 0 | 1,160 | $ 1,160 |
Balances at Jun. 30, 2015 | $ 156 | $ (809) | 24,344 | (105) | 23,586 |
Balances (in shares) at Jun. 30, 2015 | 15,575,041 | (191,250) | |||
Exercise of stock options | $ 1 | $ 0 | 312 | 0 | 313 |
Exercise of stock options (in shares) | 112,425 | 0 | |||
Stock-based compensation | $ 0 | $ 0 | 676 | 0 | 676 |
Issuance of restricted stock | $ 1 | $ 0 | (1) | 0 | 0 |
Issuance of restricted stock (in shares) | 52,992 | 0 | |||
Shares repurchased | $ 0 | $ (745) | 0 | 0 | $ (745) |
Shares repurchased (in shares) | 0 | (104,365) | (104,365) | ||
Net income (loss) | $ 0 | $ 0 | 0 | 13 | $ 13 |
Balances at Jun. 30, 2016 | $ 158 | $ (1,554) | 25,331 | (92) | $ 23,843 |
Balances (in shares) at Jun. 30, 2016 | 15,740,458 | (295,615) | 15,444,843 | ||
Exercise of stock options | $ 1 | $ 0 | 341 | 0 | $ 342 |
Exercise of stock options (in shares) | 95,050 | 0 | |||
Issuance of common shares for acquisition | $ 4 | $ 0 | 1,895 | 0 | 1,899 |
Issuance of common shares for acquisition (in shares) | 415,527 | 0 | |||
Stock-based compensation | $ 0 | $ 0 | 496 | 0 | 496 |
Issuance of restricted stock | $ 0 | $ 0 | 0 | 0 | $ 0 |
Issuance of restricted stock (in shares) | 52,992 | 0 | |||
Shares repurchased (in shares) | 0 | ||||
Net income (loss) | $ 0 | $ 0 | 0 | (1,293) | $ (1,293) |
Balances at Jun. 30, 2017 | $ 163 | $ (1,554) | $ 28,063 | $ (1,385) | $ 25,287 |
Balances (in shares) at Jun. 30, 2017 | 16,304,027 | (295,615) | 16,008,412 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
CASH FLOWS FROM OPERATING ACTIVITIES | |||
Net income (loss) | $ (1,293) | $ 13 | $ 1,160 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
Depreciation and amortization | 1,485 | 816 | 830 |
Loss on inventory write-down | 0 | 17 | 0 |
Loss on disposal of property, plant and equipment | 10 | 0 | 0 |
Stock-based compensation expense | 496 | 676 | 511 |
Changes in operating assets and liabilities, net of effects of business acquisitions: | |||
Restricted cash | 0 | 0 | 111 |
Accounts receivable | (1,244) | 926 | (1,919) |
Legal settlement receivable | 0 | 0 | 1,538 |
Inventory | (61) | (1,055) | (1,418) |
Prepaid and other assets | (35) | (46) | (259) |
Accounts payable and accrued liabilities | 125 | (759) | 1,109 |
Deferred revenue | (61) | 600 | 499 |
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES | (578) | 1,188 | 2,162 |
CASH FLOWS FROM INVESTING ACTIVITIES | |||
Purchase of property, plant and equipment | (2,486) | (1,926) | (727) |
Cash proceeds from sale of property, plant and equipment | 23 | 0 | 0 |
Additions to intangible assets | (163) | 0 | (6) |
Payments for business acquisitions, net of cash acquired | (7,314) | (1,552) | 0 |
NET CASH USED IN INVESTING ACTIVITIES | (9,940) | (3,478) | (733) |
CASH FLOWS FROM FINANCING ACTIVITIES | |||
Proceeds from exercise of stock options | 342 | 313 | 139 |
Repayments of long-term debt | (3,184) | 0 | 0 |
Proceeds from long-term debt | 5,600 | 0 | 0 |
Shares repurchased | 0 | (745) | (128) |
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | 2,758 | (432) | 11 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (7,760) | (2,722) | 1,440 |
CASH AND CASH EQUIVALENTS, beginning of period | 12,435 | 15,157 | 13,717 |
CASH AND CASH EQUIVALENTS, end of period | 4,675 | 12,435 | 15,157 |
SUPPLEMENTAL CASH FLOW DISCLOSURES: | |||
Income taxes paid | 9 | 152 | 58 |
Interest paid on long-term debt | 107 | 0 | 0 |
NON-CASH INVESTING ACTIVITIES: | |||
Issuance of common stock for acquisition | 1,899 | 0 | 0 |
Unpaid consideration related to acquisitions | 0 | 181 | 0 |
Transfer of equipment to inventory | 118 | 143 | 0 |
Property, plant and equipment financed through accounts payable | $ 28 | $ 0 | $ 0 |
ORGANIZATION AND BACKGROUND
ORGANIZATION AND BACKGROUND | 12 Months Ended |
Jun. 30, 2017 | |
ORGANIZATION AND BACKGROUND [Abstract] | |
ORGANIZATION AND BACKGROUND | NOTE 1 - ORGANIZATION AND BACKGROUND Organization Business ® ® SM ® ® . Concentration of Customers and Service Providers . For the fiscal year ended June 30, 2017, one customer represented approximately 17% of revenues. This customer also represented approximately 10%, or $0.8 million, of the total accounts receivable balance as of June 30, 2017. For the fiscal year ended June 30, 2016, one customer represented approximately 17% of revenues and 17%, or $1.0 million, of the total accounts receivable balance as of June 30, 2016. For the fiscal year ended June 30, 2015, one customer represented approximately 17% of revenues. The Company may be adversely affected by its dependence Currently, the majority of Sharps transportation is sourced with the United States Postal Service (“USPS”), which consists of delivering the Sharps Recovery System from the end user to the Company’s facilities. The Company also has an arrangement with United Parcel Service Inc. (“UPS”) whereby UPS transports certain of the Company’s products from the end user to the Company’s facilities. Sharps maintains relationships with multiple raw materials suppliers and vendors in order to meet customer demands and assure availability of our products and solutions. With respect to the Sharps Recovery System solutions, the Company owns proprietary molds and dies and utilizes several contract manufacturers for the production of the primary raw materials. Sharps believes that alternative suitable contract manufacturers are readily available to meet the production specifications of our products and solutions. The Company utilizes national suppliers for the majority of the raw materials used in our other products and solutions and international suppliers for Pitch-It IV Poles. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Jun. 30, 2017 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Revenue Recognition The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During the fiscal years ended June 30, 2017, 2016 and 2015, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $3.4 million, $3.2 million and $2.6 million, respectively. As of June 30, 2017 and 2016, $2.7 million and $2.1 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program. Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities. Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale. Business Combinations Income Taxes The income tax provision reflects the full benefit of all positions that have been taken in the Company’s income tax returns, except to the extent that such positions are uncertain and fall below the recognition requirements. In the event that the Company determines that a tax position meets the uncertainty criteria, an additional liability or benefit will result. The amount of unrecognized tax benefit requires management to make significant assumptions about the expected outcomes of certain tax positions included in filed or yet to be filed tax returns. At June 30, 2017 and 2016, the Company did not have any uncertain tax positions. The Company is subject to income taxes in the United States and in numerous state tax jurisdictions. Tax return filings which are subject to review by federal and state tax authorities by jurisdiction are as follows: · United States – fiscal years ended June 30, 2014 and after · State of Texas – fiscal years ended June 30, 2012 and after · State of Georgia – fiscal years ended June 30, 2014 and after · State of Pennsylvania – fiscal years ended June 30, 2014 and after · Other States – fiscal years ended June 30, 2013 and after None of the Company’s federal or state tax returns are currently under examination. The Company records income tax related interest and penalties, if applicable, as a component of the provision for income tax expense. However, there were no such amounts recognized in the consolidated statements of operations in 2017, 2016 and 2015. Accounts Receivable Allowance for Doubtful Accounts Balance Beginning of Year Charges to Expense Write-offs /Payments Balance End of Year 2017 $ 63 $ 20 $ (5 ) $ 78 2016 $ 34 $ 34 $ (5 ) $ 63 2015 $ 23 $ 22 $ (11 ) $ 34 Stock-Based Compensation: Year Ended June 30, 2017 2016 2015 Stock-based compensation expense included in: Cost of revenue $ 41 $ 31 $ 22 Selling, general and administrative 455 645 489 Total $ 496 $ 676 $ 511 The Company estimates the fair value of restricted stock awards based on the closing price of the Company’s common stock on the date of the grant. The Company estimates the fair value of stock options using the Black-Scholes valuation model. Key input assumptions used to estimate the fair value of stock options include the exercise price of the award, the expected option term, the expected volatility of the Company’s stock over the option’s expected term, the risk free interest rate over the option’s expected term and the Company’s expected annual dividend yield. The risk free interest rate is derived using the U.S. Treasury yield curve in effect at date of grant. Volatility, expected life and dividend yield are based on historical experience and activity. The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Year Ended June 30, 2017 2016 2015 Weighted average risk-free interest rate 1.1 % 1.0 % 0.4 % Weighted average expected volatility 47 % 45 % 45 % Weighted average expected life (in years) 5.15 4.56 3.49 Dividend yield - - - The Company considers an estimated forfeiture rate for stock options based on historical experience and the anticipated forfeiture rates during the future contract life. Cash and Cash Equivalents Inventory Property, Plant and Equipment Computer and software development costs, which include costs of computer software developed or obtained for internal use, all programming, implementation and costs incurred with developing internal-use software, are capitalized during the development project stage. External direct costs of materials and services consumed in developing or obtaining internal-use computer software are capitalized. The Company expenses costs associated with developing or obtaining internal-use software during the preliminary project stage. Training and maintenance costs associated with system changes or internal-use software are expensed as incurred. Additionally, the costs of data cleansing, reconciliation, balancing of old data to the new system, creation of new/additional data and data conversion costs are expensed as incurred. Goodwill and Other Identifiable Intangible Assets: The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the years ended June 30, 2017, 2016 and 2015. Intangible Assets Shipping and Handling Fees and Costs Additional Product Related Costs Advertising Costs Research and Development Costs Realization of Long-lived Assets Employee Benefit Plans Net Income (Loss) Per Share Fair Value of Financial Instruments Fair Value Measurements · Level 1 – Quoted prices in active markets for identical assets or liabilities. · Level 2 – Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities). · Level 3 – Significant unobservable inputs (including our own assumptions in determining fair value). We use the cost, income or market valuation approaches to estimate the fair value of our assets and liabilities when insufficient market-observable data is available to support our valuation assumptions. The purchase price allocations relating to the acquisitions completed during the years ended June 30, 2017 and 2016 utilized level 3 inputs. Segment Reporting Use of Estimates Recently Issued Accounting Standards In July 2015, guidance for inventory measurement was issued, which supersedes the policy currently followed by the Company. The new guidance requires the Company to measure inventory at the lower of cost and net realizable value. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within that reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures. In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. evaluating the impact of the new guidance on its consolidated financial statements In March 2016, new guidance for stock-based compensation was issued, which simplifies the accounting for stock-based compensation related to income taxes and balance sheet and cash flow classifications. In addition, an entity can make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material In January 2017, guidance for goodwill was issued which simplifies the test for goodwill impairment. The new guidance eliminates Step 2 of the goodwill impairment test and requires a goodwill impairment to be measured as the amount by which the Company’s carrying amount exceeds its fair value, not to exceed the carrying amount of its goodwill. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2019 (effective July 1, 2020 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the impairment recognized in future periods. In September 2015, guidance for business combinations was issued, which simplifies the accounting for measurement-period adjustments. The new guidance eliminates the requirement to restate prior period financial statements for measurement period adjustments following a business combination and requires that the cumulative impact of a measurement period adjustment (including the impact on prior periods) be recognized in the reporting period in which the adjustment is identified. The provisions of the new guidance were effective for annual reporting periods beginning after December 15, 2015 (effective July 1, 2016 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2016 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the reporting of future acquisitions if and when they occur. |
PROPERTY, PLANT AND EQUIPMENT
PROPERTY, PLANT AND EQUIPMENT | 12 Months Ended |
Jun. 30, 2017 | |
PROPERTY, PLANT AND EQUIPMENT [Abstract] | |
PROPERTY, PLANT AND EQUIPMENT | NOTE 3 – PROPERTY, PLANT AND EQUIPMENT At June 30, 2017 and 2016, property, plant and equipment consisted of the following (in thousands): June 30, Useful Life 2017 2016 Furniture and fixtures 3 to 5 years $ 260 $ 247 Plant and equipment 3 to 17 years 7,975 6,524 Manufacturing 15 years 220 220 Computers and software 3 to 5 years 2,246 2,009 Leasehold improvements Life of Lease 2,681 964 Land 19 19 Construction-in-progress 347 1,372 13,748 11,355 Less: accumulated depreciation 7,205 6,323 Net property, plant and equipment $ 6,543 $ 5,032 Total depreciation and amortization expense in the fiscal years ended June 30, 2017, 2016 and 2015 was $0.9 million, $0.7 million and $0.8 million, respectively. Depreciation expense included in cost of revenues in the fiscal years ended 2017, 2016 and 2015 was $0.7 million, $0.5 million and $0.6 million, respectively. |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
Jun. 30, 2017 | |
INCOME TAXES [Abstract] | |
INCOME TAXES | NOTE 4 – INCOME TAXES The components of income tax expense are as follows (in thousands): Year ended June 30, 2017 2016 2015 Current Federal $ - $ - $ 29 State 4 24 83 $ 4 $ 24 $ 112 The reconciliation of the statutory income tax rate to the Company’s effective income tax rate for the fiscal years ended June 30, 2017, 2016 and 2015 is as follows : Year Ended June 30, 2017 2016 2015 Statutory rate 34.0 % 34.0 % 34.0 % State income taxes, net (4.5 %) (18.6 %) 5.3 % Meals and entertainment (1.5 %) 38.7 % 1.2 % AMT and research and development credits 0.0 % (218.9 %) 0.0 % Other 0.2 % 1.5 % 0.0 % Effective rate before valuation allowance 28.2 % (163.3 %) 40.5 % Change in valuation allowance (28.5 %) 228.2 % (31.7 %) Effective tax rate (0.3 %) 64.9 % 8.8 % A valuation allowance has been recorded to reduce the Company’s net deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes. The establishment of valuation allowances and development of projected annual effective tax rates requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. At June 30, 2017 and 2016, the significant components of deferred tax assets and liabilities are approximated as follows (in thousands): June 30, 2017 2016 Deferred tax assets relating to: Stock compensation $ 398 $ 627 AMT and research and development credits 523 523 Deferred rent 77 82 Inventory 211 169 Professional fees 155 140 Accrued vacation 43 33 Accounts receivable allowance 49 24 Contribution carryovers 12 8 Net operating loss carryforwards 1,443 1,044 Total deferred tax assets 2,911 2,650 Deferred tax liablities related to depreciation differences (783 ) (621 ) Net deferred tax assets before valuation allowance 2,128 2,029 Valuation allowance (2,128 ) (2,029 ) Net deferred tax assets $ - $ - At June 30, 2017, the Company had net operating loss carryforwards of $4.8 million which will expire, if unused, between June 30, 2032 and June 30, 2037. At June 30, 2017, the Company had various tax credit carryforwards of $0.5 million, of which $0.3 million will expire beginning on June 30, 2030 and $0.2 million which may be carried forward indefinitely. As of June 30, 2017, the Company’s estimated net operating losses for tax return filing purposes exceeds the gross amount for financial reporting purposes by $0.6 million related to excess income tax benefits on stock-based compensation. The tax effect of this excess tax expense will be offset by the valuation allowance and have no net effect. |
NOTES PAYABLE AND LONG-TERM DEB
NOTES PAYABLE AND LONG-TERM DEBT | 12 Months Ended |
Jun. 30, 2017 | |
NOTES PAYABLE AND LONG-TERM DEBT [Abstract] | |
NOTES PAYABLE AND LONG-TERM DEBT | NOTE 5 - NOTES PAYABLE AND LONG-TERM DEBT On March 29, 2017, the Company entered into to a credit agreement with a commercial bank (the “Credit Agreement”). The Credit Agreement, which replaced the Company’s prior credit agreement, provides for a $14.0 million credit facility, the proceeds of which may be utilized as follows: (i) $6.0 million for working capital, letters of credit (up to $2.0 million) and general corporate purposes and (ii) $8.0 million for acquisitions. Indebtedness under the Credit Agreement is secured by substantially all of the borrower’s assets with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to 80% of eligible accounts receivable plus the lessor of 50% of eligible inventory and $3 million. Advances under the acquisition portion of the credit facility are limited to 75% of the purchase price of an acquired company and convert to a five-year term note at the time of the borrowing. Borrowings bear interest at the greater of (a) zero percent or (b) the One Month ICE LIBOR plus a LIBOR Margin of 2.5%. The LIBOR Margin may increase to as high as 3.0% after September 30, 2017 depending on the Company’s cash flow leverage ratio. The interest rate as of June 30, 2017 was approximately 3.63%. The Company pays a fee of 0.25% per annum on the unused amount of the credit facility. At June 30, 2017, long-term debt consisted of the following (in thousands): Non-interest bearing, unsecured note payable assumed in acquisition (See Note 12), monthly payments of $7; maturing September 2018. $ 104 Term loan, bearing interest at 3.63%, monthly payments of $43; maturing March 2022. 2,499 Total long-term debt 2,603 Less: current portion 601 Long-term debt, net of current portion $ 2,002 The Company has availability under the Credit Agreement of $11.5 million ($6.0 million for the working capital and $5.5 million for the acquisitions) as of June 30, 2017 which may be limited by its leverage covenant. The Company also has $10,000 in letters of credit outstanding as of June 30, 2017. The Credit Agreement contains affirmative and negative covenants that, among other things, require the Company to maintain, beginning with the twelve-month period ending September 30, 2017, a maximum cash flow leverage ratio of no more than 3.5 to 1.0 and a minimum debt service coverage ratio of not less than 1.15 to 1.00. The maximum cash flow leverage ratio decreases to 3.25 to 1.0 on December 31, 2017 and to 3.0 to 1.0 on March 31, 2018. The Credit Agreement, which expires on March 29, 2019, also contains customary events of default which, if uncured, may terminate the Credit Agreement and require immediate repayment of all indebtedness to the lenders. Payments due on long-term debt during each of the five years subsequent to June 30, 2017 are as follows (in thousands): Twelve Months Ending June 30, 2018 $ 601 2019 537 2020 517 2021 517 2022 431 $ 2,603 The prior credit agreement, which was effective through March 29, 2017, provided for a $9.0 million line of credit facility with a maturity date of April 9, 2018. No amounts related to the prior credit agreement were outstanding as of June 30, 2017. |
EQUITY TRANSACTIONS
EQUITY TRANSACTIONS | 12 Months Ended |
Jun. 30, 2017 | |
EQUITY TRANSACTIONS [Abstract] | |
EQUITY TRANSACTIONS | NOTE 6 - EQUITY TRANSACTIONS On January 7, 2013, the Company announced that its Board of Directors approved a stock repurchase program effective January 3, 2013, authorizing the Company to repurchase in the aggregate up to $3 million of its outstanding common stock over a two-year period. On March 5, 2015, the Board approved a two-year extension of the stock repurchase program through January 1, 2017. The program has not been extended. During the years ended June 30, 2017, 2016 and 2015, shares were repurchased as follows: Year Ended June 30, 2017 2016 2015 Shares repurchased - 104,365 29,449 Cash paid for shares repurchased (in thousands) $ - $ 745 $ 128 Average price paid per share $ - $ 7.14 $ 4.35 Total shares repurchased under the program are 295,615 shares at a cost of $1.6 million. |
STOCK BASED COMPENSATION
STOCK BASED COMPENSATION | 12 Months Ended |
Jun. 30, 2017 | |
STOCK BASED COMPENSATION [Abstract] | |
STOCK BASED COMPENSATION | NOTE 7 - STOCK BASED COMPENSATION The Company sponsors the Sharps Compliance Corp. 2010 Stock Plan (the “2010 Plan”) covering employees, consultants and non-employee directors. The 2010 Stock Plan replaced the Sharps Compliance Corp. 1993 Stock Plan (the “1993 Plan”). The 2010 Plan provides for the granting of stock-based compensation (stock options or restricted stock) of up to 3,000,000 shares of the Company’s common stock of which 877,904 options and restrict ed shares are outstanding as of June 30, 2017. Options granted generally vest over a period of three to four years and expire seven The summary of activity for all restricted stock during the fiscal years ended June 30, 2017, 2016 and 2015 Year Ended June 30, 2017 2016 2015 Unvested at beginning of the year 13 13 15 Granted 53 53 53 Vested (53 ) (53 ) (55 ) Unvested at end of the year 13 13 13 The summary of activity for all stock options during the fiscal years ended June 30, 2017, 2016 and 2015 is presented in the table below (in thousands except per share amounts): Options Outstanding Weighted Average Exercise Price Options Outstanding at June 30, 2014 950 $ 4.27 Granted 516 $ 4.63 Exercised (61 ) $ 2.30 Forfeited or canceled (30 ) $ 4.68 Options Outstanding at June 30, 2015 1,375 $ 4.49 Granted 45 $ 6.62 Exercised (112 ) $ 2.77 Forfeited or canceled (18 ) $ 5.99 Options Outstanding at June 30, 2016 1,290 $ 4.69 Granted 38 $ 4.55 Exercised (95 ) $ 3.60 Forfeited or canceled (368 ) $ 5.32 Options Outstanding at June 30, 2017 865 $ 4.53 Options Exercisable at June 30, 2017 561 $ 4.39 The following table summarizes information about stock options outstanding as of June 30, 2017 (in thousands except per share amounts): Options Outstanding Range of Exercise Price Outstanding as of Weighted Average Remaining Life Weighted Average Exercise Price $ 2.51 - $3.50 41 2.49 $ 2.95 $ 3.51 - $5.50 692 3.27 $ 4.35 $ 5.51 - $7.50 132 4.82 $ 5.97 865 $ 4.53 The following table summarizes information about stock options exercisable as of June 30, 2017 (in thousands except per share amounts): Options Exercisable Range of Exercise Price Exercisable as of Weighted Average Remaining Life Weighted Average Exercise Price $ 2.51 - $3.50 39 2.46 $ 2.96 $ 3.51 - $5.50 464 2.66 $ 4.32 $ 5.51 - $7.50 58 4.78 $ 5.87 561 $ 4.39 As of June 30, 2017, there was $0.2 million of stock option and restricted stock compensation expense related to non-vested awards. This expense is expected to be recognized over a weighted average period of 1.6 years. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 12 Months Ended |
Jun. 30, 2017 | |
COMMITMENTS AND CONTINGENCIES [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 8 - COMMITMENTS AND CONTINGENCIES Operating Leases: Rent expense for the fiscal years ended June 30, 2017, 2016 and 2015 was $2.3 million, $1.5 million and $1.3 million, respectively. Future minimum lease payments under non-cancelable operating leases as of June 30, 2017 are as follows (in thousands): Year Ended June 30, 2018 2019 2020 2021 2022 Thereafter Operating lease obligations $ 1,812 $ 1,827 $ 1,725 $ 943 $ 274 $ 5 Performance Bonds: Other the Company is involved in legal proceedings and litigation in the ordinary course of business. In the opinion of management, the outcome of such matters will not have a material adverse effect on the Company’s consolidated financial position or consolidated results of operations. |
EARNINGS PER SHARE
EARNINGS PER SHARE | 12 Months Ended |
Jun. 30, 2017 | |
EARNINGS PER SHARE [Abstract] | |
EARNINGS PER SHARE | NOTE 9 - EARNINGS PER SHARE Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares after considering the additional dilution related to common stock options and restricted stock. In computing diluted earnings per share, the outstanding common stock options are considered dilutive using the treasury stock method. The Company’s restricted stock awards are treated as outstanding for earnings per share calculations since these shares have full voting rights and are entitled to participate in dividends declared on common shares, if any, and undistributed earnings. As participating securities, the shares of restricted stock are included in the calculation of basic EPS using the two-class method. For the periods presented, the amount of earnings allocated to the participating securities was not material. The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per share amounts): Year Ended June 30, 2017 2016 2015 Net income (loss), as reported $ (1,293 ) $ 13 $ 1,160 Weighted average common shares outstanding 15,949 15,448 15,327 Effect of dilutive stock options - 390 237 Weighted average diluted common shares outstanding 15,949 15,838 15,564 Net income (loss) per common share Basic $ (0.08 ) $ 0.00 $ 0.08 Diluted $ (0.08 ) $ 0.00 $ 0.07 Employee stock options excluded from computation of diluted income per share amounts because their effect would be anti-dilutive 304 137 210 |
GOODWILL AND INTANGIBLE ASSETS
GOODWILL AND INTANGIBLE ASSETS | 12 Months Ended |
Jun. 30, 2017 | |
GOODWILL AND INTANGIBLE ASSETS [Abstract] | |
GOODWILL AND INTANGIBLE ASSETS | NOTE 10 – GOODWILL AND INTANGIBLE ASSETS At June 30, 2017 and June 30, 2016, intangible assets consisted of the following (in thousands): June 30, 2017 2016 Estimated Useful Lives Original Amount Accumulated Amortization Net Amount Original Amount Accumulated Amortization Net Amount Customer relationships 7 years $ 3,007 $ (490 ) $ 2,517 $ 580 $ (60 ) $ 520 Permits 6 - 15 years 1,373 (288 ) 1,085 668 (191 ) 477 Patents 5 - 17 years 383 (264 ) 119 383 (251 ) 132 Tradename 7 years 270 (39 ) 231 - - - Non-compete 5 years 117 (23 ) 94 - - - Total intangible assets, net $ 5,150 $ (1,104 ) $ 4,046 $ 1,631 $ (502 ) $ 1,129 During the years ended June 30, 2017, 2016 and 2015 amortization expense was $0.6 million, $0.1 million and $0.1 million, respectively. The changes in the carrying amount of goodwill since June 30, 2015 was as follows (in thousands): Year Ended June 30, 2017 2016 Beginning Balance $ 1,039 $ - Goodwill Acquired 5,696 1,039 Ending Balance $ 6,735 $ 1,039 As of June 30, 2017, future amortization of intangible assets is as follows (in thousands): Year Ending June 30, 2018 $ 616 2019 616 2020 616 2021 615 2022 590 Thereafter 993 $ 4,046 |
REVENUES BY SOLUTION
REVENUES BY SOLUTION | 12 Months Ended |
Jun. 30, 2017 | |
REVENUES BY SOLUTION [Abstract] | |
REVENUES BY SOLUTION | NOTE 11 – REVENUES BY SOLUTION The components of revenues by solution are as follows (dollars in thousands): Year Ended June 30, 2017 % Total 2016 % Total 2015 % Total REVENUES BY SOLUTION: Mailbacks $ 24,135 63.2 % $ 23,743 71.1 % $ 23,043 74.6 % Route-based pickup services 6,348 16.6 % 2,061 6.2 % 862 2.8 % Unused medications 3,377 8.8 % 3,531 10.6 % 2,667 8.6 % Third party treatment services 413 1.1 % 258 0.8 % 367 1.2 % Other (1) 3,915 10.3 % 3,790 11.3 % 3,963 12.8 % Total revenues $ 38,188 100.0 % $ 33,383 100.0 % $ 30,902 100.0 % (1) The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items. |
ACQUISITIONS
ACQUISITIONS | 12 Months Ended |
Jun. 30, 2017 | |
ACQUISITIONS [Abstract] | |
ACQUISITIONS | NOTE 12 – ACQUISITIONS Effective on July 17, 2015, the Company acquired Alpha Bio/Med Services LLC, a route-based pickup service located in Pennsylvania for total cash consideration of $0.7 million of which $0.1 million was withheld for payment of adjusted escrow amounts which settled in July 2016. The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 51 Fixed assets 70 Intangibles 267 Goodwill 413 Accounts payable and accrued liabilities (101 ) Total purchase price $ 700 Effective on December 14, 2015, the Company acquired Bio-Team Mobile LLC, a route-based pickup service located in Pennsylvania for total cash consideration of $1.0 million of which $0.1 million was withheld for payment of adjusted escrow amounts which settled in January 2017. The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 42 Fixed assets 68 Intangibles 313 Goodwill 626 Accounts payable and accrued liabilities (16 ) Total purchase price $ 1,033 Effective July 1, 2016, the Company acquired Citiwaste, LLC (“Citiwaste”), a route-based pickup service located in New York, which is in the business of medical, pharmaceutical and hazardous waste management primarily in the healthcare industry. The purchase price consisted of $7.0 million in cash ($3.0 million of which was borrowed under the acquisition portion of its Credit Agreement), 415,527 shares of common stock of the Company (the “Common Stock Consideration”) valued at $1.9 million, and a lease obligation paid to the seller for $0.1 million for a total consideration of $9.0 million. The issuance of the Common Stock Consideration was not registered under the Securities Act of 1933, as amended, and was issued pursuant to an exemption from the registration requirements thereunder. The Company held shares of the Common Stock Consideration in escrow for the one-year period to cover indemnification obligations of the sellers under the purchase agreement For the year ended June 30, 2017, the Company recognized approximately $3.6 million in revenues related to the operations of Citiwaste. The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Cash $ 5 Accounts receivable 495 Fixed assets 30 Intangibles 3,357 Goodwill 5,696 Accounts payable and accrued liabilities (356 ) Debt assumed (187 ) Total purchase price $ 9,040 The Company incurred acquisition related expenses for investment banking, legal and accounting fees which are included within selling, general and administrative expenses in the consolidated statements of operations as follows (in thousands): Twelve-Months Ended June 30, 2017 2016 2015 Acquisition-related expenses $ 702 $ 190 $ - The results of operations of the acquired business have been included in the consolidated statements of operations from the date of acquisition. Pro forma results of operations for Alpha Bio/Med Services and Bio-Team Mobile are not presented because the pro forma effects, individually or in the aggregate, were not material to the Company’s consolidated results of operations. The goodwill recorded for the Alpha Bio/Med Services, Bio-Team Mobile, and Citiwaste acquisitions will be deductible for income taxes. The goodwill recognized for the acquisitions since July 1, 2015 is attributable to expected revenue synergies generated by the integration of our products and services with those acquisitions, cost synergies resulting from the consolidation or elimination of certain functions, and intangible assets that do not qualify for separate recognition such as the assembled workforce of each acquisition. Supplemental Pro Forma Data (Unaudited) Citiwaste’s financial results since the date of the acquisition have been included in our consolidated financial results for the year ended June 30, 2017. The following table presents summarized unaudited pro forma financial information as if the Citiwaste acquisition occurred on July 1, 2015 (in thousands, except per-share data): Twelve-Months Ended June 30, 2016 Revenues $ 36,306 Net income (loss) $ (159 ) Weighted average common shares outstanding 15,861 Net loss per common share basic and diluted $ (0.01 ) The pro forma financial information for the period presented includes the estimated business combination accounting effects resulting from the acquisition, including primarily amortization expense of $0.5 million from the acquired intangible assets as well as interest expense as a result of debt financing used to fund the acquisition and tax effects from the pro forma adjustments. |
SELECTED QUARTERLY FINANCIAL DA
SELECTED QUARTERLY FINANCIAL DATA | 12 Months Ended |
Jun. 30, 2017 | |
SELECTED QUARTERLY FINANCIAL DATA [Abstract] | |
SELECTED QUARTERLY FINANCIAL DATA | NOTE 13 – SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED) The following tables show quarterly financial information for the years ended June 30, 2017 and 2016. The Company believes that all necessary adjustments have been included in the amounts below to present fairly the results of such periods (in thousands expect per share amounts). Quarter Ended September 30, 2016 December 31, 2016 March 31, 2017 June 30, 2017 Total revenues $ 9,531 $ 9,707 $ 8,588 $ 10,362 Gross profit $ 2,959 $ 2,895 $ 2,352 $ 3,631 Operating income (loss) $ (940 ) $ (204 ) $ (638 ) $ 595 Net income (loss) $ (967 ) $ (227 ) $ (668 ) $ 569 Net income (loss) per share - basic and diluted $ (0.06 ) $ (0.01 ) $ (0.04 ) $ 0.04 Weighted average shares-diluted 15,868 15,929 15,994 16,029 Quarter Ended September 30, 2015 December 31, 2015 March 31, 2016 June 30, 2016 Total revenues $ 7,869 $ 9,992 $ 6,652 $ 8,870 Gross profit $ 2,879 $ 3,319 $ 1,693 $ 3,220 Operating income (loss) $ 231 $ 664 $ (1,104 ) $ 214 Net income (loss) $ 220 $ 615 $ (1,042 ) $ 220 Net income (loss) per share - basic and diluted $ 0.01 $ 0.04 $ (0.07 ) $ 0.01 Weighted average shares-diluted 15,926 16,062 15,462 15,575 |
SUMMARY OF SIGNIFICANT ACCOUN20
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Jun. 30, 2017 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | |
Revenue Recognition | Revenue Recognition The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During the fiscal years ended June 30, 2017, 2016 and 2015, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $3.4 million, $3.2 million and $2.6 million, respectively. As of June 30, 2017 and 2016, $2.7 million and $2.1 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program. Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities. Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale. |
Business Combinations | Business Combinations |
Income Taxes | Income Taxes The income tax provision reflects the full benefit of all positions that have been taken in the Company’s income tax returns, except to the extent that such positions are uncertain and fall below the recognition requirements. In the event that the Company determines that a tax position meets the uncertainty criteria, an additional liability or benefit will result. The amount of unrecognized tax benefit requires management to make significant assumptions about the expected outcomes of certain tax positions included in filed or yet to be filed tax returns. At June 30, 2017 and 2016, the Company did not have any uncertain tax positions. The Company is subject to income taxes in the United States and in numerous state tax jurisdictions. Tax return filings which are subject to review by federal and state tax authorities by jurisdiction are as follows: · United States – fiscal years ended June 30, 2014 and after · State of Texas – fiscal years ended June 30, 2012 and after · State of Georgia – fiscal years ended June 30, 2014 and after · State of Pennsylvania – fiscal years ended June 30, 2014 and after · Other States – fiscal years ended June 30, 2013 and after None of the Company’s federal or state tax returns are currently under examination. The Company records income tax related interest and penalties, if applicable, as a component of the provision for income tax expense. However, there were no such amounts recognized in the consolidated statements of operations in 2017, 2016 and 2015. |
Accounts Receivable | Accounts Receivable Allowance for Doubtful Accounts Balance Beginning of Year Charges to Expense Write-offs /Payments Balance End of Year 2017 $ 63 $ 20 $ (5 ) $ 78 2016 $ 34 $ 34 $ (5 ) $ 63 2015 $ 23 $ 22 $ (11 ) $ 34 |
Stock-Based Compensation | Stock-Based Compensation: Year Ended June 30, 2017 2016 2015 Stock-based compensation expense included in: Cost of revenue $ 41 $ 31 $ 22 Selling, general and administrative 455 645 489 Total $ 496 $ 676 $ 511 The Company estimates the fair value of restricted stock awards based on the closing price of the Company’s common stock on the date of the grant. The Company estimates the fair value of stock options using the Black-Scholes valuation model. Key input assumptions used to estimate the fair value of stock options include the exercise price of the award, the expected option term, the expected volatility of the Company’s stock over the option’s expected term, the risk free interest rate over the option’s expected term and the Company’s expected annual dividend yield. The risk free interest rate is derived using the U.S. Treasury yield curve in effect at date of grant. Volatility, expected life and dividend yield are based on historical experience and activity. The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Year Ended June 30, 2017 2016 2015 Weighted average risk-free interest rate 1.1 % 1.0 % 0.4 % Weighted average expected volatility 47 % 45 % 45 % Weighted average expected life (in years) 5.15 4.56 3.49 Dividend yield - - - The Company considers an estimated forfeiture rate for stock options based on historical experience and the anticipated forfeiture rates during the future contract life. |
Cash and Cash Equivalents | Cash and Cash Equivalents |
Inventory | Inventory |
Property, Plant and Equipment | Property, Plant and Equipment Computer and software development costs, which include costs of computer software developed or obtained for internal use, all programming, implementation and costs incurred with developing internal-use software, are capitalized during the development project stage. External direct costs of materials and services consumed in developing or obtaining internal-use computer software are capitalized. The Company expenses costs associated with developing or obtaining internal-use software during the preliminary project stage. Training and maintenance costs associated with system changes or internal-use software are expensed as incurred. Additionally, the costs of data cleansing, reconciliation, balancing of old data to the new system, creation of new/additional data and data conversion costs are expensed as incurred. |
Goodwill and Other Identifiable Intangible Assets | Goodwill and Other Identifiable Intangible Assets: The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the years ended June 30, 2017, 2016 and 2015. |
Intangible Assets | Intangible Assets |
Shipping and Handling Fees and Costs | Shipping and Handling Fees and Costs |
Additional Product Related Costs | Additional Product Related Costs |
Advertising Costs | Advertising Costs |
Research and Development Costs | Research and Development Costs |
Realization of Long-lived Assets | Realization of Long-lived Assets |
Employee Benefit Plans | Employee Benefit Plans |
Net Income (Loss) Per Share | Net Income (Loss) Per Share |
Fair Value of Financial Instruments | Fair Value of Financial Instruments |
Fair Value Measurements | Fair Value Measurements · Level 1 – Quoted prices in active markets for identical assets or liabilities. · Level 2 – Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities). · Level 3 – Significant unobservable inputs (including our own assumptions in determining fair value). We use the cost, income or market valuation approaches to estimate the fair value of our assets and liabilities when insufficient market-observable data is available to support our valuation assumptions. The purchase price allocations relating to the acquisitions completed during the years ended June 30, 2017 and 2016 utilized level 3 inputs. |
Segment Reporting | Segment Reporting |
Use of Estimates | Use of Estimates |
Recently Issued Accounting Standards | Recently Issued Accounting Standards In July 2015, guidance for inventory measurement was issued, which supersedes the policy currently followed by the Company. The new guidance requires the Company to measure inventory at the lower of cost and net realizable value. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within that reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures. In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. evaluating the impact of the new guidance on its consolidated financial statements In March 2016, new guidance for stock-based compensation was issued, which simplifies the accounting for stock-based compensation related to income taxes and balance sheet and cash flow classifications. In addition, an entity can make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material In January 2017, guidance for goodwill was issued which simplifies the test for goodwill impairment. The new guidance eliminates Step 2 of the goodwill impairment test and requires a goodwill impairment to be measured as the amount by which the Company’s carrying amount exceeds its fair value, not to exceed the carrying amount of its goodwill. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2019 (effective July 1, 2020 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the impairment recognized in future periods. In September 2015, guidance for business combinations was issued, which simplifies the accounting for measurement-period adjustments. The new guidance eliminates the requirement to restate prior period financial statements for measurement period adjustments following a business combination and requires that the cumulative impact of a measurement period adjustment (including the impact on prior periods) be recognized in the reporting period in which the adjustment is identified. The provisions of the new guidance were effective for annual reporting periods beginning after December 15, 2015 (effective July 1, 2016 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2016 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the reporting of future acquisitions if and when they occur. |
SUMMARY OF SIGNIFICANT ACCOUN21
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | |
Allowance for doubtful accounts | The Company has a history of minimal uncollectible accounts. See rollforward of allowance activity below: Allowance for Doubtful Accounts Balance Beginning of Year Charges to Expense Write-offs /Payments Balance End of Year 2017 $ 63 $ 20 $ (5 ) $ 78 2016 $ 34 $ 34 $ (5 ) $ 63 2015 $ 23 $ 22 $ (11 ) $ 34 |
Schedule of stock-based compensation expense | Total stock-based compensation expense for the fiscal years ended June 30, 2017, 2016 and 2015 are as follows: Year Ended June 30, 2017 2016 2015 Stock-based compensation expense included in: Cost of revenue $ 41 $ 31 $ 22 Selling, general and administrative 455 645 489 Total $ 496 $ 676 $ 511 |
Schedule of stock option valuation assumptions | The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Year Ended June 30, 2017 2016 2015 Weighted average risk-free interest rate 1.1 % 1.0 % 0.4 % Weighted average expected volatility 47 % 45 % 45 % Weighted average expected life (in years) 5.15 4.56 3.49 Dividend yield - - - |
PROPERTY, PLANT AND EQUIPMENT (
PROPERTY, PLANT AND EQUIPMENT (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
PROPERTY, PLANT AND EQUIPMENT [Abstract] | |
Property, plant and equipment | At June 30, 2017 and 2016, property, plant and equipment consisted of the following (in thousands): June 30, Useful Life 2017 2016 Furniture and fixtures 3 to 5 years $ 260 $ 247 Plant and equipment 3 to 17 years 7,975 6,524 Manufacturing 15 years 220 220 Computers and software 3 to 5 years 2,246 2,009 Leasehold improvements Life of Lease 2,681 964 Land 19 19 Construction-in-progress 347 1,372 13,748 11,355 Less: accumulated depreciation 7,205 6,323 Net property, plant and equipment $ 6,543 $ 5,032 |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
INCOME TAXES [Abstract] | |
Components of income tax expense | The components of income tax expense are as follows (in thousands): Year ended June 30, 2017 2016 2015 Current Federal $ - $ - $ 29 State 4 24 83 $ 4 $ 24 $ 112 |
Effective income tax rate reconciliation | The reconciliation of the statutory income tax rate to the Company’s effective income tax rate for the fiscal years ended June 30, 2017, 2016 and 2015 is as follows : Year Ended June 30, 2017 2016 2015 Statutory rate 34.0 % 34.0 % 34.0 % State income taxes, net (4.5 %) (18.6 %) 5.3 % Meals and entertainment (1.5 %) 38.7 % 1.2 % AMT and research and development credits 0.0 % (218.9 %) 0.0 % Other 0.2 % 1.5 % 0.0 % Effective rate before valuation allowance 28.2 % (163.3 %) 40.5 % Change in valuation allowance (28.5 %) 228.2 % (31.7 %) Effective tax rate (0.3 %) 64.9 % 8.8 % |
Components of deferred tax assets and liabilities | At June 30, 2017 and 2016, the significant components of deferred tax assets and liabilities are approximated as follows (in thousands): June 30, 2017 2016 Deferred tax assets relating to: Stock compensation $ 398 $ 627 AMT and research and development credits 523 523 Deferred rent 77 82 Inventory 211 169 Professional fees 155 140 Accrued vacation 43 33 Accounts receivable allowance 49 24 Contribution carryovers 12 8 Net operating loss carryforwards 1,443 1,044 Total deferred tax assets 2,911 2,650 Deferred tax liablities related to depreciation differences (783 ) (621 ) Net deferred tax assets before valuation allowance 2,128 2,029 Valuation allowance (2,128 ) (2,029 ) Net deferred tax assets $ - $ - |
NOTES PAYABLE AND LONG-TERM D24
NOTES PAYABLE AND LONG-TERM DEBT (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
NOTES PAYABLE AND LONG-TERM DEBT [Abstract] | |
Schedule of long-term debt | At June 30, 2017, long-term debt consisted of the following (in thousands): Non-interest bearing, unsecured note payable assumed in acquisition (See Note 12), monthly payments of $7; maturing September 2018. $ 104 Term loan, bearing interest at 3.63%, monthly payments of $43; maturing March 2022. 2,499 Total long-term debt 2,603 Less: current portion 601 Long-term debt, net of current portion $ 2,002 |
Schedule of payments due on long-term debt | Payments due on long-term debt during each of the five years subsequent to June 30, 2017 are as follows (in thousands): Twelve Months Ending June 30, 2018 $ 601 2019 537 2020 517 2021 517 2022 431 $ 2,603 |
EQUITY TRANSACTIONS (Tables)
EQUITY TRANSACTIONS (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
EQUITY TRANSACTIONS [Abstract] | |
Schedule of share repurchases | The program has not been extended. During the years ended June 30, 2017, 2016 and 2015, shares were repurchased as follows: Year Ended June 30, 2017 2016 2015 Shares repurchased - 104,365 29,449 Cash paid for shares repurchased (in thousands) $ - $ 745 $ 128 Average price paid per share $ - $ 7.14 $ 4.35 |
STOCK BASED COMPENSATION (Table
STOCK BASED COMPENSATION (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
STOCK BASED COMPENSATION [Abstract] | |
Schedule of activity for all restricted stock | The summary of activity for all restricted stock during the fiscal years ended June 30, 2017, 2016 and 2015 Year Ended June 30, 2017 2016 2015 Unvested at beginning of the year 13 13 15 Granted 53 53 53 Vested (53 ) (53 ) (55 ) Unvested at end of the year 13 13 13 |
Schedule of activity for all stock options | The summary of activity for all stock options during the fiscal years ended June 30, 2017, 2016 and 2015 is presented in the table below (in thousands except per share amounts): Options Outstanding Weighted Average Exercise Price Options Outstanding at June 30, 2014 950 $ 4.27 Granted 516 $ 4.63 Exercised (61 ) $ 2.30 Forfeited or canceled (30 ) $ 4.68 Options Outstanding at June 30, 2015 1,375 $ 4.49 Granted 45 $ 6.62 Exercised (112 ) $ 2.77 Forfeited or canceled (18 ) $ 5.99 Options Outstanding at June 30, 2016 1,290 $ 4.69 Granted 38 $ 4.55 Exercised (95 ) $ 3.60 Forfeited or canceled (368 ) $ 5.32 Options Outstanding at June 30, 2017 865 $ 4.53 Options Exercisable at June 30, 2017 561 $ 4.39 |
Schedule of information about stock options outstanding | The following table summarizes information about stock options outstanding as of June 30, 2017 (in thousands except per share amounts): Options Outstanding Range of Exercise Price Outstanding as of Weighted Average Remaining Life Weighted Average Exercise Price $ 2.51 - $3.50 41 2.49 $ 2.95 $ 3.51 - $5.50 692 3.27 $ 4.35 $ 5.51 - $7.50 132 4.82 $ 5.97 865 $ 4.53 |
Schedule of information about stock options exercisable | The following table summarizes information about stock options exercisable as of June 30, 2017 (in thousands except per share amounts): Options Exercisable Range of Exercise Price Exercisable as of Weighted Average Remaining Life Weighted Average Exercise Price $ 2.51 - $3.50 39 2.46 $ 2.96 $ 3.51 - $5.50 464 2.66 $ 4.32 $ 5.51 - $7.50 58 4.78 $ 5.87 561 $ 4.39 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
COMMITMENTS AND CONTINGENCIES [Abstract] | |
Operating lease obligations | Future minimum lease payments under non-cancelable operating leases as of June 30, 2017 are as follows (in thousands): Year Ended June 30, 2018 2019 2020 2021 2022 Thereafter Operating lease obligations $ 1,812 $ 1,827 $ 1,725 $ 943 $ 274 $ 5 |
EARNINGS PER SHARE (Tables)
EARNINGS PER SHARE (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
EARNINGS PER SHARE [Abstract] | |
Earnings per share | The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per share amounts): Year Ended June 30, 2017 2016 2015 Net income (loss), as reported $ (1,293 ) $ 13 $ 1,160 Weighted average common shares outstanding 15,949 15,448 15,327 Effect of dilutive stock options - 390 237 Weighted average diluted common shares outstanding 15,949 15,838 15,564 Net income (loss) per common share Basic $ (0.08 ) $ 0.00 $ 0.08 Diluted $ (0.08 ) $ 0.00 $ 0.07 Employee stock options excluded from computation of diluted income per share amounts because their effect would be anti-dilutive 304 137 210 |
GOODWILL AND INTANGIBLE ASSETS
GOODWILL AND INTANGIBLE ASSETS (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
GOODWILL AND INTANGIBLE ASSETS [Abstract] | |
Schedule of intangible assets | At June 30, 2017 and June 30, 2016, intangible assets consisted of the following (in thousands): June 30, 2017 2016 Estimated Useful Lives Original Amount Accumulated Amortization Net Amount Original Amount Accumulated Amortization Net Amount Customer relationships 7 years $ 3,007 $ (490 ) $ 2,517 $ 580 $ (60 ) $ 520 Permits 6 - 15 years 1,373 (288 ) 1,085 668 (191 ) 477 Patents 5 - 17 years 383 (264 ) 119 383 (251 ) 132 Tradename 7 years 270 (39 ) 231 - - - Non-compete 5 years 117 (23 ) 94 - - - Total intangible assets, net $ 5,150 $ (1,104 ) $ 4,046 $ 1,631 $ (502 ) $ 1,129 |
Schedule of goodwill | The changes in the carrying amount of goodwill since June 30, 2015 was as follows (in thousands): Year Ended June 30, 2017 2016 Beginning Balance $ 1,039 $ - Goodwill Acquired 5,696 1,039 Ending Balance $ 6,735 $ 1,039 |
Schedule of future amortization of intangible assets | As of June 30, 2017, future amortization of intangible assets is as follows (in thousands): Year Ending June 30, 2018 $ 616 2019 616 2020 616 2021 615 2022 590 Thereafter 993 $ 4,046 |
REVENUES BY SOLUTION (Tables)
REVENUES BY SOLUTION (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
REVENUES BY SOLUTION [Abstract] | |
Schedule of billings by solution | The components of revenues by solution are as follows (dollars in thousands): Year Ended June 30, 2017 % Total 2016 % Total 2015 % Total REVENUES BY SOLUTION: Mailbacks $ 24,135 63.2 % $ 23,743 71.1 % $ 23,043 74.6 % Route-based pickup services 6,348 16.6 % 2,061 6.2 % 862 2.8 % Unused medications 3,377 8.8 % 3,531 10.6 % 2,667 8.6 % Third party treatment services 413 1.1 % 258 0.8 % 367 1.2 % Other (1) 3,915 10.3 % 3,790 11.3 % 3,963 12.8 % Total revenues $ 38,188 100.0 % $ 33,383 100.0 % $ 30,902 100.0 % (1) The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items. |
ACQUISITIONS (Tables)
ACQUISITIONS (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
Business Acquisition [Line Items] | |
Summary of acquisition related costs | The Company incurred acquisition related expenses for investment banking, legal and accounting fees which are included within selling, general and administrative expenses in the consolidated statements of operations as follows (in thousands): Twelve-Months Ended June 30, 2017 2016 2015 Acquisition-related expenses $ 702 $ 190 $ - |
Summary of unaudited pro forma financial information | The following table presents summarized unaudited pro forma financial information as if the Citiwaste acquisition occurred on July 1, 2015 (in thousands, except per-share data): Twelve-Months Ended June 30, 2016 Revenues $ 36,306 Net income (loss) $ (159 ) Weighted average common shares outstanding 15,861 Net loss per common share basic and diluted $ (0.01 ) |
Alpha Bio/Med Services LLC [Member] | |
Business Acquisition [Line Items] | |
Preliminary purchase price allocation | The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 51 Fixed assets 70 Intangibles 267 Goodwill 413 Accounts payable and accrued liabilities (101 ) Total purchase price $ 700 |
Bio-Team Mobile LLC [Member] | |
Business Acquisition [Line Items] | |
Preliminary purchase price allocation | The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 42 Fixed assets 68 Intangibles 313 Goodwill 626 Accounts payable and accrued liabilities (16 ) Total purchase price $ 1,033 |
Citiwaste LLC [Member] | |
Business Acquisition [Line Items] | |
Preliminary purchase price allocation | The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Cash $ 5 Accounts receivable 495 Fixed assets 30 Intangibles 3,357 Goodwill 5,696 Accounts payable and accrued liabilities (356 ) Debt assumed (187 ) Total purchase price $ 9,040 |
SELECTED QUARTERLY FINANCIAL 32
SELECTED QUARTERLY FINANCIAL DATA (Tables) | 12 Months Ended |
Jun. 30, 2017 | |
SELECTED QUARTERLY FINANCIAL DATA [Abstract] | |
Schedule of quarterly financial information | The following tables show quarterly financial information for the years ended June 30, 2017 and 2016. The Company believes that all necessary adjustments have been included in the amounts below to present fairly the results of such periods (in thousands expect per share amounts). Quarter Ended September 30, 2016 December 31, 2016 March 31, 2017 June 30, 2017 Total revenues $ 9,531 $ 9,707 $ 8,588 $ 10,362 Gross profit $ 2,959 $ 2,895 $ 2,352 $ 3,631 Operating income (loss) $ (940 ) $ (204 ) $ (638 ) $ 595 Net income (loss) $ (967 ) $ (227 ) $ (668 ) $ 569 Net income (loss) per share - basic and diluted $ (0.06 ) $ (0.01 ) $ (0.04 ) $ 0.04 Weighted average shares-diluted 15,868 15,929 15,994 16,029 Quarter Ended September 30, 2015 December 31, 2015 March 31, 2016 June 30, 2016 Total revenues $ 7,869 $ 9,992 $ 6,652 $ 8,870 Gross profit $ 2,879 $ 3,319 $ 1,693 $ 3,220 Operating income (loss) $ 231 $ 664 $ (1,104 ) $ 214 Net income (loss) $ 220 $ 615 $ (1,042 ) $ 220 Net income (loss) per share - basic and diluted $ 0.01 $ 0.04 $ (0.07 ) $ 0.01 Weighted average shares-diluted 15,926 16,062 15,462 15,575 |
ORGANIZATION AND BACKGROUND (De
ORGANIZATION AND BACKGROUND (Details) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017USD ($)StateRegionCustomer | Jun. 30, 2016USD ($)Customer | Jun. 30, 2015Customer | |
Concentration Risk [Line Items] | |||
Number of route-based pick-up service in state region | StateRegion | 23 | ||
Concentration risk, percentage | 100.00% | 100.00% | 100.00% |
Accounts receivable | $ | $ 7,553 | $ 5,814 | |
Customer Concentration Risk [Member] | Sales Revenue, Services, Net [Member] | |||
Concentration Risk [Line Items] | |||
Number of customers | Customer | 1 | 1 | 1 |
Concentration risk, percentage | 17.00% | 17.00% | 17.00% |
Credit Concentration Risk [Member] | Accounts Receivable [Member] | |||
Concentration Risk [Line Items] | |||
Number of customers | Customer | 1 | 1 | |
Concentration risk, percentage | 10.00% | 17.00% | |
Accounts receivable | $ | $ 800 | $ 1,000 |
SUMMARY OF SIGNIFICANT ACCOUN34
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Revenue Recognition (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Revenue Recognition [Abstract] | |||
Revenue recorded from bill and hold inventory | $ 3.4 | $ 3.2 | $ 2.6 |
Bill and hold inventory | $ 2.7 | $ 2.1 |
SUMMARY OF SIGNIFICANT ACCOUN35
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Jun. 30, 2017 | Jun. 30, 2016 | |
Income Taxes [Abstract] | ||
Liability for uncertain tax positions | $ 0 | $ 0 |
Internal Revenue Service (IRS) [Member] | Minimum [Member] | ||
Income Tax Contingency [Line Items] | ||
Open tax years | 2,014 | |
State of Texas [Member] | Minimum [Member] | ||
Income Tax Contingency [Line Items] | ||
Open tax years | 2,012 | |
State of Georgia [Member] | Minimum [Member] | ||
Income Tax Contingency [Line Items] | ||
Open tax years | 2,014 | |
States of Pennsylvania [Member] | Minimum [Member] | ||
Income Tax Contingency [Line Items] | ||
Open tax years | 2,014 | |
Other States [Member] | Minimum [Member] | ||
Income Tax Contingency [Line Items] | ||
Open tax years | 2,013 |
SUMMARY OF SIGNIFICANT ACCOUN36
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Accounts Receivable (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Allowance for Doubtful Accounts [Roll Forward] | |||
Balance beginning of year | $ 63 | $ 34 | $ 23 |
Charges to expense | 20 | 34 | 22 |
Write-offs /payments | (5) | (5) | (11) |
Balance end of year | $ 78 | $ 63 | $ 34 |
SUMMARY OF SIGNIFICANT ACCOUN37
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Stock-Based Compensation (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Stock-based compensation expense | $ 496 | $ 676 | $ 511 |
Valuation assumptions [Abstract] | |||
Weighted average risk-free interest rate | 1.10% | 1.00% | 0.40% |
Weighted average expected volatility | 47.00% | 45.00% | 45.00% |
Weighted average expected life | 5 years 1 month 24 days | 4 years 6 months 22 days | 3 years 5 months 26 days |
Dividend yield | 0.00% | 0.00% | 0.00% |
Cost of Revenue [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Stock-based compensation expense | $ 41 | $ 31 | $ 22 |
Selling, General and Administrative [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Stock-based compensation expense | $ 455 | $ 645 | $ 489 |
SUMMARY OF SIGNIFICANT ACCOUN38
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents and Inventory (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Inventory [Abstract] | |||
Total inventory | $ 4,098 | $ 3,919 | |
Finished goods | 2,800 | 2,500 | |
Raw materials | 1,300 | 1,400 | |
Loss on inventory write-down | 0 | 17 | $ 0 |
Goodwill and Other Identifiable Intangible Assets | |||
Goodwill impairment loss | $ 0 | $ 0 | $ 0 |
SUMMARY OF SIGNIFICANT ACCOUN39
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Intangible Assets (Details) - Patent | 1 Months Ended | 12 Months Ended | ||||||||
Jan. 30, 2014 | Nov. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Aug. 31, 2012 | Apr. 30, 2012 | Jan. 31, 2012 | Nov. 30, 2003 | Jun. 30, 1998 | Jun. 30, 2017 | |
Intangible Assets [Abstract] | ||||||||||
Intangible assets description | Intangible assets consist of (i) acquired customer relationships, (ii) permit costs related to the Company’s treatment facility in Carthage, Texas, and (iii) eleven patents (two acquired in June 1998, one in November 2003, one in January 2012, two in April 2012, one in August 2012, one in September 2012, one in December 2012, one in November 2013 and one in January 2014), and (iv) defense costs related to certain existing patents. | |||||||||
Number of patents acquired | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 11 |
SUMMARY OF SIGNIFICANT ACCOUN40
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Advertising Costs, Research, Development Costs and Realization of Long-lived Assets (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Advertising Costs [Abstract] | |||
Advertising costs | $ 0.8 | $ 0.6 | $ 0.6 |
Realization of Long-lived Assets [Abstract] | |||
Impairment losses recognized | 0 | 0 | 0 |
Maximum [Member] | |||
Research and Development Expenses [Line Items] | |||
Research and development expenses | $ 0.1 | $ 0.1 | $ 0.1 |
SUMMARY OF SIGNIFICANT ACCOUN41
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Employee Benefit Plans (Details) - USD ($) | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Defined Contribution Plan Disclosure [Line Items] | |||
Employers match percentage | 25.00% | ||
Maximum annual percentage contribution per employee | 6.00% | ||
Prior group health benefit plan, individual deductible | $ 2,500 | ||
Group health benefit plan, family deductible | 2,500 | ||
Group health benefit plan, third party insurance company coverage beginning amount, individual | 2,500 | ||
Group health benefit plan, third party insurance company coverage beginning amount, family | 10,000 | ||
Maximum [Member] | |||
Defined Contribution Plan Disclosure [Line Items] | |||
Company contributions to the 401(k) plan | 100,000 | $ 100,000 | $ 100,000 |
Self-insured liability, health insurance | 100,000 | 100,000 | |
Executives [Member] | |||
Defined Contribution Plan Disclosure [Line Items] | |||
Aggregate stock-based compensation expense | $ 0 | $ 0 | $ 300,000 |
PROPERTY, PLANT AND EQUIPMENT42
PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Property, Plant and Equipment [Line Items] | |||
Gross property, plant and equipment | $ 13,748 | $ 11,355 | |
Less: accumulated depreciation | 7,205 | 6,323 | |
Net property, plant and equipment | 6,543 | 5,032 | |
Depreciation and amortization expense | 900 | 700 | $ 800 |
Depreciation expense included in cost of revenues | 700 | 500 | $ 600 |
Furniture and Fixtures [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Gross property, plant and equipment | $ 260 | 247 | |
Furniture and Fixtures [Member] | Minimum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 3 years | ||
Furniture and Fixtures [Member] | Maximum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 5 years | ||
Plant and Equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Gross property, plant and equipment | $ 7,975 | 6,524 | |
Plant and Equipment [Member] | Minimum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 3 years | ||
Plant and Equipment [Member] | Maximum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 17 years | ||
Manufacturing [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 15 years | ||
Gross property, plant and equipment | $ 220 | 220 | |
Computers and Software [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Gross property, plant and equipment | $ 2,246 | 2,009 | |
Computers and Software [Member] | Minimum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 3 years | ||
Computers and Software [Member] | Maximum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 5 years | ||
Leasehold Improvements [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Gross property, plant and equipment | $ 2,681 | 964 | |
Land [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Gross property, plant and equipment | 19 | 19 | |
Construction in Progress [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Gross property, plant and equipment | $ 347 | $ 1,372 |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Current [Abstract] | |||
Federal | $ 0 | $ 0 | $ 29 |
State | 4 | 24 | 83 |
Current income tax expense, total | $ 4 | $ 24 | $ 112 |
Effective income tax rate reconciliation [Abstract] | |||
Statutory rate | 34.00% | 34.00% | 34.00% |
State income taxes, net | (4.50%) | (18.60%) | 5.30% |
Meals and entertainment | (1.50%) | 38.70% | 1.20% |
AMT and research and development credits | 0.00% | (218.90%) | 0.00% |
Other | 0.20% | 1.50% | 0.00% |
Effective rate before valuation allowance | 28.20% | (163.30%) | 40.50% |
Change in valuation allowance | (28.50%) | 228.20% | (31.70%) |
Effective tax rate | (0.30%) | 64.90% | 8.80% |
Deferred tax assets relating to [Abstract] | |||
Stock compensation | $ 398 | $ 627 | |
AMT and research and development credits | 523 | 523 | |
Deferred rent | 77 | 82 | |
Inventory | 211 | 169 | |
Professional fees | 155 | 140 | |
Accrued vacation | 43 | 33 | |
Accounts receivable allowance | 49 | 24 | |
Contribution carryovers | 12 | 8 | |
Net operating loss carryforwards | 1,443 | 1,044 | |
Total deferred tax assets | 2,911 | 2,650 | |
Deferred tax liabilities related to depreciation differences | (783) | (621) | |
Net deferred tax assets before valuation allowance | 2,128 | 2,029 | |
Valuation allowance | (2,128) | (2,029) | |
Net deferred tax assets | 0 | $ 0 | |
Tax Credit Carryforward [Line Items] | |||
Net operating loss carryforwards | 4,800 | ||
Tax credit carryforward, amount | 500 | ||
Tax credit carryforward, amount expiration indefinitely | $ 200 | ||
Tax credit carryforward, expiration date | indefinitely | ||
Estimated net operating losses for tax return exceeds the gross amount | $ 600 | ||
Minimum [Member] | |||
Tax Credit Carryforward [Line Items] | |||
Operating loss carryforwards, expiration dates | Jun. 30, 2032 | ||
Maximum [Member] | |||
Tax Credit Carryforward [Line Items] | |||
Operating loss carryforwards, expiration dates | Jun. 30, 2037 | ||
2030 [Member] | |||
Tax Credit Carryforward [Line Items] | |||
Tax credit carryforward, amount | $ 300 | ||
Tax credit carryforward, expiration date | Jun. 30, 2030 |
NOTES PAYABLE AND LONG-TERM D44
NOTES PAYABLE AND LONG-TERM DEBT (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Dec. 31, 2016 | Jun. 30, 2016 | |
Long-term debt [Abstract] | |||
Total long-term debt | $ 2,603 | ||
Less: current portion | 601 | $ 0 | |
Long-term debt, net of current portion | 2,002 | $ 0 | |
Unsecured Note Payable [Member] | |||
Long-term debt [Abstract] | |||
Monthly payments | $ 7 | ||
Maturity date | Sep. 30, 2018 | ||
Total long-term debt | $ 104 | ||
Term Loan [Member] | |||
Line of Credit Facility [Line Items] | |||
Maturity period | 5 years | ||
Interest rate | 3.63% | ||
Long-term debt [Abstract] | |||
Monthly payments | $ 43 | ||
Maturity date | Mar. 31, 2022 | ||
Total long-term debt | $ 2,499 | ||
Credit Agreement [Member] | |||
Line of Credit Facility [Line Items] | |||
Maximum borrowing capacity | $ 14,000 | ||
Percentage of eligible accounts receivable considered for borrowing base | 80.00% | ||
Percentage of eligible inventory considered for borrowing base | 50.00% | ||
Amount of convenant for borrowing base | $ 3,000 | ||
Unused capacity, commitment fee percentage | 0.25% | ||
Remaining borrowing capacity | $ 11,500 | ||
Basis spread of variable rate | 0.00% | ||
Credit Agreement [Member] | Minimum [Member] | |||
Line of Credit Facility [Line Items] | |||
Debt service coverage ratio | 1.15 | ||
Credit Agreement [Member] | Maximum [Member] | |||
Line of Credit Facility [Line Items] | |||
Debt cash flow leverage ratio | 3.5 | ||
Debt cash flow of leverage ratio as on December 31, 2017 | 3.25 | ||
Decrease in cash flow of leverage ratio as on March 31, 2018 | 3 | ||
Credit Agreement [Member] | LIBOR [Member] | |||
Line of Credit Facility [Line Items] | |||
Debt instrument, term of variable rate | 1 month | ||
Basis spread of variable rate | 2.50% | ||
Credit Agreement [Member] | LIBOR [Member] | Maximum [Member] | |||
Line of Credit Facility [Line Items] | |||
Basis spread of variable rate | 3.00% | ||
Credit Agreement [Member] | Working Capital [Member] | |||
Line of Credit Facility [Line Items] | |||
Maximum borrowing capacity | $ 6,000 | ||
Remaining borrowing capacity | 6,000 | ||
Credit Agreement [Member] | Letters of Credit [Member] | |||
Line of Credit Facility [Line Items] | |||
Maximum borrowing capacity | 2,000 | ||
Amount outstanding | 10 | ||
Credit Agreement [Member] | Acquisitions [Member] | |||
Line of Credit Facility [Line Items] | |||
Maximum borrowing capacity | $ 8,000 | ||
Percentage of portion allocated to acquisition purchase price | 75.00% | ||
Remaining borrowing capacity | $ 5,500 | ||
Prior Credit Agreement [Member] | |||
Line of Credit Facility [Line Items] | |||
Maximum borrowing capacity | $ 9,000 | ||
Line of credit facility outstanding | $ 0 | ||
Long-term debt [Abstract] | |||
Maturity date | Apr. 9, 2018 |
NOTES PAYABLE AND LONG-TERM D45
NOTES PAYABLE AND LONG-TERM DEBT, Payments Due on Long-term Debt (Details) $ in Thousands | Jun. 30, 2017USD ($) |
Payments due on long-term debt [Abstract] | |
2,018 | $ 601 |
2,019 | 537 |
2,020 | 517 |
2,021 | 517 |
2,022 | 431 |
Total long-term debt | $ 2,603 |
EQUITY TRANSACTIONS (Details)
EQUITY TRANSACTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | Jan. 07, 2013 | |
EQUITY TRANSACTIONS [Abstract] | ||||
Stock repurchase program, authorized amount | $ 3,000 | |||
Stock repurchase program, period | 2 years | |||
Stock repurchase program term extension | 2 years | |||
Shares repurchased [Abstract] | ||||
Shares repurchased (in shares) | 0 | 104,365 | 29,449 | |
Cash paid for shares repurchased | $ 0 | $ 745 | $ 128 | |
Average price paid per share (in dollars per share) | $ 0 | $ 7.14 | $ 4.35 | |
Total shares repurchased under the program (in shares) | 295,615 | 295,615 | ||
Total shares repurchased under the program, at cost | $ 1,554 | $ 1,554 |
STOCK BASED COMPENSATION (Detai
STOCK BASED COMPENSATION (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Non-vested award [Abstract] | |||
Expense for non-vested awards | $ 200 | ||
Weighted average period for expense recognition | 1 year 7 months 6 days | ||
Stock Options [Member] | |||
Stock Option Activity [Rollforward] | |||
Options outstanding at beginning of period (in shares) | 1,290,000 | 1,375,000 | 950,000 |
Granted (in shares) | 38,000 | 45,000 | 516,000 |
Exercised (in shares) | (95,000) | (112,000) | (61,000) |
Forfeited or canceled (in shares) | (368,000) | (18,000) | (30,000) |
Options outstanding at end of period (in shares) | 865,000 | 1,290,000 | 1,375,000 |
Options exercisable (in shares) | 561,000 | ||
Weighted Average Exercise Price [Abstract] | |||
Options outstanding at beginning of period (in dollars per share) | $ 4.69 | $ 4.49 | $ 4.27 |
Granted (in dollars per share) | 4.55 | 6.62 | 4.63 |
Exercised (in dollars per share) | 3.60 | 2.77 | 2.30 |
Forfeited or canceled (in dollars per share) | 5.32 | 5.99 | 4.68 |
Options outstanding at end of period (in dollars per share) | 4.53 | $ 4.69 | $ 4.49 |
Options exercisable (in dollars per share) | $ 4.39 | ||
Restricted Stock [Member] | |||
Restricted stock activity [Rollforward] | |||
Unvested at beginning of the year (in shares) | 13,000 | 13,000 | 15,000 |
Granted (in shares) | 53,000 | 53,000 | 53,000 |
Vested (in shares) | (53,000) | (53,000) | (55,000) |
Unvested at end of the year (in shares) | 13,000 | 13,000 | 13,000 |
Weighted Average Fair Value [Abstract] | |||
Grants (in dollars per share) | $ 4.38 | $ 8 | $ 4.28 |
Vested (in dollars per share) | $ 5.29 | $ 7.07 | $ 4.44 |
2010 Stock Plan [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of common shares authorized (in shares) | 3,000,000 | ||
Shares outstanding (in shares) | 877,904 | ||
Options available for grant (in shares) | 1,561,891 | ||
2010 Stock Plan [Member] | Stock Options [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expiration period | 7 years | ||
2010 Stock Plan [Member] | Stock Options [Member] | Minimum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 3 years | ||
2010 Stock Plan [Member] | Stock Options [Member] | Maximum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 4 years | ||
2010 Stock Plan [Member] | Restricted Stock [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 1 year | ||
1993 Stock Plan [Member] | Stock Options [Member] | |||
Stock Option Activity [Rollforward] | |||
Options outstanding at end of period (in shares) | 0 |
STOCK BASED COMPENSATION, Stock
STOCK BASED COMPENSATION, Stock options exercisable (Details) shares in Thousands | 12 Months Ended |
Jun. 30, 2017$ / sharesshares | |
Options Outstanding [Abstract] | |
Outstanding (in shares) | shares | 865 |
Weighted average exercise price (in dollars per share) | $ 4.53 |
Options Exercisable [Abstract] | |
Exercisable (in shares) | shares | 561 |
Weighted average exercise price (in dollars per share) | $ 4.39 |
$2.51-$3.50 [Member] | |
Options Outstanding [Abstract] | |
Range of exercise price, minimum (in dollars per share) | 2.51 |
Range of exercise price, maximum (in dollars per share) | $ 3.50 |
Outstanding (in shares) | shares | 41 |
Weighted average remaining life | 2 years 5 months 26 days |
Weighted average exercise price (in dollars per share) | $ 2.95 |
Options Exercisable [Abstract] | |
Exercisable (in shares) | shares | 39 |
Weighted average remaining life | 2 years 5 months 16 days |
Weighted average exercise price (in dollars per share) | $ 2.96 |
$3.51-$5.50 [Member] | |
Options Outstanding [Abstract] | |
Range of exercise price, minimum (in dollars per share) | 3.51 |
Range of exercise price, maximum (in dollars per share) | $ 5.50 |
Outstanding (in shares) | shares | 692 |
Weighted average remaining life | 3 years 3 months 7 days |
Weighted average exercise price (in dollars per share) | $ 4.35 |
Options Exercisable [Abstract] | |
Exercisable (in shares) | shares | 464 |
Weighted average remaining life | 2 years 7 months 28 days |
Weighted average exercise price (in dollars per share) | $ 4.32 |
$5.51-$7.50 [Member] | |
Options Outstanding [Abstract] | |
Range of exercise price, minimum (in dollars per share) | 5.51 |
Range of exercise price, maximum (in dollars per share) | $ 7.50 |
Outstanding (in shares) | shares | 132 |
Weighted average remaining life | 4 years 9 months 25 days |
Weighted average exercise price (in dollars per share) | $ 5.97 |
Options Exercisable [Abstract] | |
Exercisable (in shares) | shares | 58 |
Weighted average remaining life | 4 years 9 months 11 days |
Weighted average exercise price (in dollars per share) | $ 5.87 |
COMMITMENTS AND CONTINGENCIES49
COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017USD ($)Facility | Jun. 30, 2016USD ($) | Jun. 30, 2015USD ($) | |
Operating Leases [Line Items] | |||
Number of fully-permitted facility | Facility | 2 | ||
Rent expense | $ 2,300 | $ 1,500 | $ 1,300 |
Future minimum lease payments [Abstract] | |||
2,018 | 1,812 | ||
2,019 | 1,827 | ||
2,020 | 1,725 | ||
2,021 | 943 | ||
2,022 | 274 | ||
Thereafter | 5 | ||
Maximum [Member] | |||
Future minimum lease payments [Abstract] | |||
Performance bonds outstanding covering financial assurance | $ 600 | ||
U.S [Member] | Minimum [Member] | |||
Operating Leases [Line Items] | |||
Option to renew lease, term | 3 years | ||
U.S [Member] | Maximum [Member] | |||
Operating Leases [Line Items] | |||
Option to renew lease, term | 10 years |
EARNINGS PER SHARE (Details)
EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2015 | Sep. 30, 2015 | Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
EARNINGS PER SHARE [Abstract] | |||||||||||
Net (income) loss, as reported | $ 569 | $ (668) | $ (227) | $ (967) | $ 220 | $ (1,042) | $ 615 | $ 220 | $ (1,293) | $ 13 | $ 1,160 |
Weighted average common shares outstanding (in shares) | 15,949 | 15,448 | 15,327 | ||||||||
Effect of dilutive stock options (in shares) | 0 | 390 | 237 | ||||||||
Weighted average diluted common shares outstanding (in shares) | 16,029 | 15,994 | 15,929 | 15,868 | 15,575 | 15,462 | 16,062 | 15,926 | 15,949 | 15,838 | 15,564 |
Net income (loss) per common share [Abstract] | |||||||||||
Basic (in dollars per share) | $ (0.08) | $ 0 | $ 0.08 | ||||||||
Diluted (in dollars per share) | $ (0.08) | $ 0 | $ 0.07 | ||||||||
Employee stock options excluded from computation of diluted income per share amounts because their effect would be anti-dilutive (in shares) | 304 | 137 | 210 |
GOODWILL AND INTANGIBLE ASSET51
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets, original amount | $ 5,150 | $ 1,631 | |
Intangible assets, accumulated amortization | (1,104) | (502) | |
Total | 4,046 | 1,129 | |
Intangible assets, amortization expense | 600 | 100 | $ 100 |
Goodwill [Roll Forward] | |||
Beginning Balance | 1,039 | 0 | |
Goodwill Acquired | 5,696 | 1,039 | |
Ending Balance | 6,735 | 1,039 | $ 0 |
Future amortization of intangible assets [Abstract] | |||
2,018 | 616 | ||
2,019 | 616 | ||
2,020 | 616 | ||
2,021 | 615 | ||
2,022 | 590 | ||
Thereafter | 993 | ||
Total | $ 4,046 | 1,129 | |
Customer Relationships [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Estimated useful lives | 7 years | ||
Intangible assets, original amount | $ 3,007 | 580 | |
Intangible assets, accumulated amortization | (490) | (60) | |
Total | 2,517 | 520 | |
Future amortization of intangible assets [Abstract] | |||
Total | 2,517 | 520 | |
Permits [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets, original amount | 1,373 | 668 | |
Intangible assets, accumulated amortization | (288) | (191) | |
Total | 1,085 | 477 | |
Future amortization of intangible assets [Abstract] | |||
Total | $ 1,085 | 477 | |
Permits [Member] | Minimum [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Estimated useful lives | 6 years | ||
Permits [Member] | Maximum [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Estimated useful lives | 15 years | ||
Patents [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets, original amount | $ 383 | 383 | |
Intangible assets, accumulated amortization | (264) | (251) | |
Total | 119 | 132 | |
Future amortization of intangible assets [Abstract] | |||
Total | $ 119 | 132 | |
Patents [Member] | Minimum [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Estimated useful lives | 5 years | ||
Patents [Member] | Maximum [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Estimated useful lives | 17 years | ||
Trade Name [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Estimated useful lives | 7 years | ||
Intangible assets, original amount | $ 270 | 0 | |
Intangible assets, accumulated amortization | (39) | 0 | |
Total | 231 | 0 | |
Future amortization of intangible assets [Abstract] | |||
Total | $ 231 | 0 | |
Non-compete [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Estimated useful lives | 5 years | ||
Intangible assets, original amount | $ 117 | 0 | |
Intangible assets, accumulated amortization | (23) | 0 | |
Total | 94 | 0 | |
Future amortization of intangible assets [Abstract] | |||
Total | $ 94 | $ 0 |
REVENUES BY SOLUTION (Details)
REVENUES BY SOLUTION (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||||||||||
Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2015 | Sep. 30, 2015 | Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | ||
Segment Reporting Information [Line Items] | ||||||||||||
Total revenues | $ 10,362 | $ 8,588 | $ 9,707 | $ 9,531 | $ 8,870 | $ 6,652 | $ 9,992 | $ 7,869 | $ 38,188 | $ 33,383 | $ 30,902 | |
Revenue percentage | 100.00% | 100.00% | 100.00% | |||||||||
Mailbacks [Member] | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Total revenues | $ 24,135 | $ 23,743 | $ 23,043 | |||||||||
Revenue percentage | 63.20% | 71.10% | 74.60% | |||||||||
Route-based Pickup Services [Member] | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Total revenues | $ 6,348 | $ 2,061 | $ 862 | |||||||||
Revenue percentage | 16.60% | 6.20% | 2.80% | |||||||||
Unused Medications [Member] | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Total revenues | $ 3,377 | $ 3,531 | $ 2,667 | |||||||||
Revenue percentage | 8.80% | 10.60% | 8.60% | |||||||||
Third Party Treatment Services [Member] | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Total revenues | $ 413 | $ 258 | $ 367 | |||||||||
Revenue percentage | 1.10% | 0.80% | 1.20% | |||||||||
Other [Member] | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Total revenues | [1] | $ 3,915 | $ 3,790 | $ 3,963 | ||||||||
Revenue percentage | [1] | 10.30% | 11.30% | 12.80% | ||||||||
[1] | The Company's other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items. |
ACQUISITIONS (Details)
ACQUISITIONS (Details) - USD ($) $ / shares in Units, $ in Thousands | Jul. 02, 2016 | Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | Dec. 14, 2015 | Jul. 17, 2015 |
Preliminary purchase price allocation [Abstract] | ||||||
Goodwill | $ 6,735 | $ 1,039 | $ 0 | |||
Business acquisition related expenses [Abstract] | ||||||
Acquisition related expenses | 702 | 190 | 0 | |||
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] | ||||||
Amortization expense from acquired intangible assets | 600 | 100 | $ 100 | |||
Acquisition-related Costs [Member] | ||||||
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] | ||||||
Amortization expense from acquired intangible assets | $ 500 | |||||
Alpha Bio/Med Services LLC [Member] | ||||||
Preliminary purchase price allocation [Abstract] | ||||||
Accounts receivable | $ 51 | |||||
Fixed assets | 70 | |||||
Intangibles | 267 | |||||
Goodwill | 413 | |||||
Accounts payable and accrued liabilities | (101) | |||||
Total purchase price | 700 | |||||
Cash consideration withheld for possible settlement amounts | $ 100 | |||||
Bio-Team Mobile LLC [Member] | ||||||
Preliminary purchase price allocation [Abstract] | ||||||
Accounts receivable | $ 42 | |||||
Fixed assets | 68 | |||||
Intangibles | 313 | |||||
Goodwill | 626 | |||||
Accounts payable and accrued liabilities | (16) | |||||
Total purchase price | 1,033 | |||||
Cash consideration withheld for possible settlement amounts | $ 100 | |||||
Citiwaste LLC [Member] | ||||||
Preliminary purchase price allocation [Abstract] | ||||||
Cash | $ 5 | |||||
Accounts receivable | 495 | |||||
Fixed assets | 30 | |||||
Intangibles | 3,357 | |||||
Goodwill | 5,696 | |||||
Accounts payable and accrued liabilities | (356) | |||||
Debt assumed | (187) | |||||
Total purchase price | 9,040 | |||||
Purchase price of acquisition | $ 7,000 | |||||
Number of shares for purchase price of acquisition (in shares) | 415,527 | |||||
Purchase price of acquisition value | $ 1,900 | |||||
Lease obligation amount | 100 | |||||
Total consideration amount | 9,000 | |||||
Escrow period for common stock consideration | 1 year | |||||
Revenues | $ 3,600 | |||||
Supplemental pro forma data [Abstract] | ||||||
Revenues | 36,306 | |||||
Net income (loss) | $ (159) | |||||
Weighted average common shares outstanding (in shares) | 15,861,000 | |||||
Net loss per common share basic and diluted (in dollars per share) | $ (0.01) | |||||
Citiwaste LLC [Member] | Credit Agreement [Member] | ||||||
Preliminary purchase price allocation [Abstract] | ||||||
Amount outstanding | $ 3,000 |
SELECTED QUARTERLY FINANCIAL 54
SELECTED QUARTERLY FINANCIAL DATA (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2015 | Sep. 30, 2015 | Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
SELECTED QUARTERLY FINANCIAL DATA [Abstract] | |||||||||||
Total revenues | $ 10,362 | $ 8,588 | $ 9,707 | $ 9,531 | $ 8,870 | $ 6,652 | $ 9,992 | $ 7,869 | $ 38,188 | $ 33,383 | $ 30,902 |
Gross profit | 3,631 | 2,352 | 2,895 | 2,959 | 3,220 | 1,693 | 3,319 | 2,879 | 11,837 | 11,111 | 10,995 |
Operating income (loss) | 595 | (638) | (204) | (940) | 214 | (1,104) | 664 | 231 | (1,187) | 5 | 1,236 |
Net income (loss) | $ 569 | $ (668) | $ (227) | $ (967) | $ 220 | $ (1,042) | $ 615 | $ 220 | $ (1,293) | $ 13 | $ 1,160 |
Net income (loss) per share - basic and diluted (in dollars per share) | $ 0.04 | $ (0.04) | $ (0.01) | $ (0.06) | $ 0.01 | $ (0.07) | $ 0.04 | $ 0.01 | |||
Weighted average shares-diluted (in shares) | 16,029 | 15,994 | 15,929 | 15,868 | 15,575 | 15,462 | 16,062 | 15,926 | 15,949 | 15,838 | 15,564 |